1. business and industrial
2. biomedical

LEADERS OF MARCH
TOMORROW 31
SUMMIT
2015
INNOVATE
DISRUPT
LEAD
INNOVATE
DISRUPT
LEAD
Leaders of Tomorrow
SUMMIT 2015
TA B L E O F C O N T E N T S
01
Summit Mission
02
Executive Planning Team
03 - 04
Highlights / 50 Leaders of Tomorrow
05 - 31
Profiles / 50 Leaders of Tomorrow
32
Our Volunteers & Advisory Board
33 - 35
Speaker List
36 - 38
Detailed Agenda
39
Our Partners & Sponsors
1
Our Mission
for the Summit
The Summit will engage
and influence our next
generation of visionaries
and ignite innovation in
our future bioeconomy.
To unite “50 Leaders of Tomorrow”
with established leaders from
different sectors to inspire innovation,
develop leadership, grow our regional
bioeconomy, and challenge each other
through discussions and seminars.
This one-day immersive meeting
will include interactive seminars,
panel discussions, and an
innovation challenge for the
“50 Leaders of Tomorrow.”
INNOVATE
DISRUPT
LEAD
Mid-Atlantic region’s
first student-andpostdoc-led, crossfunctional, and inter-generational
leadership Summit
featuring students,
young biotech
leaders, bio-pharmaceutical industries,
government, and
entrepreneurs.
2
Executive Planning Team
Marina Carla Cabrera
President
Kirill Gorshkov
Vice President
Carla is an Innovative thinker devoted
to revolutionizing the field of personalized medicine and cancer research.
Energized to lead and motivate forward-focused teams to achieve extraordinary feats.
Adhering
to
the
principles
of
diligence and perseverance in all of
his endeavors, Kirill strives to be at
the pinnacle of scientific progress
throughout his career.
Jianqing “JQ” Li
Chief Operating Officer
Emily Billings
Speaker Liaison Director
Shirley Tan
Marketing Director
A life science Ph.D. with expertise in
immunotherapy and entrepreneurial spirit, JQ envisions himself working
closely with scientists, investors and
entrepreneurs to turn scientific discoveries into life-saving medicines.
As a Microbiology doctoral candidate
at the University of Virginia and a
recipient of the Cellular and Molecular
Biology training grant, Emily is in
interested in enhancing communication and connectivity, from the
microbial to the scientific community.
A cancer researcher turned a
novice in biotech intellectual property, Shirley is passionate
about leveraging her expertise to
bridge the gap between cutting-edge
innovation and business development in the bio-pharma enterprise.
3
4
Universities / Institutions
Where we come from
at a glance
Georgetown University
Johns Hopkins University
MedImmune
NIH
Penn State University
University of MD
University of MD Baltimore
University of Virginia
+16
Pursued an
entrepreneurial venture
+10
Started
their own business
Other
Our Career Aspirations
22% 22%
Current Focus Area
Basic Research
Biomedical Research
Policy
Law
Venture Capital
Entrepreneurship
Medicine
Business
17%
+40
Lead a
professional association or student club
+29
13%
10%
7%
4%
Received
a distinguished award
for their work
Academia Big Pharma Biotech
Consulting
Gov’t
Agencies
3%
Law Firm Medicine
Venture
Capital
Investment
Meet the 50 Leaders of Tomorrow
Executive Planning Team
M. Carla Cabrera, PhD
Postdoctoral Fellow
President, Leaders of Tomorrow Summit
5
*Executive
Planning
Committee
MedImmune
Focus: Biomedical Research
Jianqing “JQ” Li, PhD
Postdoctoral Fellow
COO, Leaders of Tomorrow Summit
*Executive
Planning
Committee
MedImmune
Focus: Biomedical Research
“Innovative thinker devoted to revolutionizing the field of personalized cancer medicine.
Energized to lead and motivate forward-focused teams to achieve extraordinary feats.
Curiosity, creativity, perseverance, and teamwork are my drivers.”
Carla is a passionate and innovative cancer research scientist exploring disruptive pathways to target cancer stem cells.
During her PhD at Georgetown University, she led a multidisciplinary team of 16 clinicians, researchers, and bioinformatics
experts on a pilot study to discover novel therapeutic solutions for patients with pancreatic cancer. She is the president of the
Leaders of Tomorrow Summit and has led the team from inception, through strategic planning, and now final implementation to execute a first-of-its-kind event for young pioneers in the MidAtlantic Region. Carla is interested in using her dynamic
set of problem solving skills, genuine curiosity, and unrelenting desire to innovate to revolutionize personalized medicine and
catalyze a paradigm shift in the treatment of cancer.
Kirill Gorshkov
PhD Candidate
Vice President, Leaders of Tomorrow
Summit
6
*Executive
Planning
Committee
Johns Hopkins School of Medicine
Focus: Biomedical Research
“Adhering to the principles of diligence and perseverance in all of my endeavors, I strive to be
at the pinnacle of scientific progress throughout my career.”
Kirill Gorshkov is the Vice President of the Leaders of Tomorrow Summit 2015. He is a 4th year Ph.D. candidate at the Johns
Hopkins School of Medicine Department of Pharmacology and Molecular Sciences under the mentorship of Dr.. Jin Zhang.
His thesis project on the role of cAMP/PKA signaling in neuronal development is funded by the NSF Graduate Research
Fellowship. He will be interning at Eli Lilly within the Diabetes department in the summer of 2015. He is also the President of
the Leadership Initiative for the Environment at Hopkins Medicine.
“A life science Ph.D. with expertise in immunotherapy and entrepreneurial spirit. I am equally
impressed by creative ideas and flawless execution.”
Dr.. Li is a well-trained immunologist focusing on host-pathogen interaction and cancer surveillance. He is also the COO of the
executive planning team for Leaders of Tomorrow Summit 2015. Prior to join MedImmune as a postdoc, he has led an international student association and provided strategic consulting service for biotech startups. Passionate about innovation, he
has worked with a multidisciplinary team to commercialize a novel viral vaccine. Planning the Leaders of Tomorrow summit
is another initiative he assumes to hone his leadership skills and connect with the top talents within the Mid-Atlantic region.
Deeply attached to scientific breakthroughs, he envisions himself working closely with scientists, investors and entrepreneurs
to turn scientific discoveries into life-saving medicines.
Emily Billings
PhD Candidate
Speaker Liaison Director, Leaders of
Tomorrow Summit
*Executive
Planning
Committee
University of Virginia
Focus: Biomedical Research
“Enhancing communication and connectivity from the microbial to the scientific community”
Emily Billings is the Speaker Liaison Director for the Leaders of Tomorrow Summit. She is a Microbiology doctoral candidate
at the University of Virginia and a recipient of the Cellular and Molecular Biology training grant. Her work focuses on the cell
biology of innate immunity, where she studies the recognition of bacteria and inflammatory responses during homeostasis and pathogenesis. As the President of the Graduate Biosciences Society, she has taken active involvement in graduate
training and the development of professional programs. Emily is an engaged science advocate, mentor, and aspiring leader.
She strives to build connections and enhance communication in a collaborative, multidisciplinary and multi-institutional
setting.
Meet the 50 Leaders of Tomorrow
7
Shirley Tan, PhD
*Executive Planning
InHouse Patent Counsel at
Committee
BioHealth Innovation
Marketing Director, Leaders of Tomorrow Summit
Technical Specialist/Legal Intern
Focus: Intellectual Property
“A fearless leader with experiences in biomedical research, business consulting, and intellectual property. I believe in the values of stronger science-business partnership to spur next-generation innovation in the biotech sector.”
A Ph.D. turned a novice in biotech Intellectual Property, Shirley is inspired to bridge the gap between scientific innovation and
business development in the bio-pharma enterprise. Prior to her ventures into the IP field, Shirley researched prostate cancer
genomics and clinical prognosis at Johns Hopkins. Within 2 years, her work was published in at least 7 research journals and
conferences. As a passionate and fearless leader, Shirley has led a consulting project for a Baltimore healthcare non-profit,
won 1st Place in a business case competition advising for Google, and co-led the Executive Team of Leaders of Tomorrow
Summit at MedImmune.
8
Omotayo Arowojolu
MD/PhD Candidate
New York University School of Medicine
Focus: Biomedical Research
“I am interested in collaborating with like-minded scientists, entrepreneurs, clinicians, and
leaders in the biotech community to develop solutions that improve patient care.”
My passion is for the advancement of science, translational medicine, and therapeutic development. My career goal is to
become a physician-scientist that treats patients and conducts cutting edge research to develop therapeutics and diagnostic
tools for clinical use. I am pursuing an MD-PhD degree in Molecular Pharmacology and my interest is in the development of
molecular targeted therapies for pigment disorders, melanoma, and other cancers. As a biotech leader of tomorrow, I look
forward to the discovery of novel scientific and clinical technologies to enhance future patient care.
Ali Afshar
PhD Candidate
Alexandra Bettina
PhD Candidate
Johns Hopkins University
Focus: Biomedical Research
University of Virginia
Focus: Biomedical Research
Ali Afshar is currently a PhD candidate in Electrical and Computer Engineering at JHU, with a Master’s in Applied Mathematics and Statistics as a joint program. His areas of interest are big data analytics for medical data and information-enabled
devices related to healthcare industries . He is also the president and founder of Technology Entrepreneurship club at the
Johns Hopkins University and has served as technical advisor and mentor for several distinguished technology-related events.
“Advocate of science communication. Inspiring and motivating others by example, leadership,
innovation, tenacity, collaboration, team building and a passion for excellence. Igniting conversation and extinguishing complacency.”
“PhD candidate in Microbiology at University of Virginia. Thesis work consists of elucidating mechanisms underlying host
immunity during Gram-negative bacterial and fungal pneumonia. Awarded funding from NIH-sponsored Infectious Diseases
Training Grant, 2012-2014. Served as chairs of academic committee to Graduate Biosciences Society and Microbiology Student
Committee at UVA, 2014-2015. These experiences have empowered me to motivate colleagues in diverse scientific fields:
my convictions have enabled me to instill enthusiasm in others to be engaged and committed to current projects. Accomplished at building teams resulting in collaborations across scientific disciplines. Results-driven and resourceful with enduring
perseverance.”
Meet the 50 Leaders of Tomorrow
9
Matthew Biggs
PhD Candidate
Eryn Dixon
Graduate Research Assistant
University of Virginia
Focus: Biomedical Research
University of Maryland, Baltimore
Focus: Biomedical Research
“I’m a computational systems biologist. I’m excited about metabolic engineering and
bioprocessing.”
I am excelling in my PhD program at the University of Virginia in terms of publishing, awards, and funding. I recently completed
an Internship at Dow Agrosciences in Bioengineering and Bioprocessing where I gained first-hand experience with a large
metabolic engineering project. I specialize in powerful computational modeling of biological systems. I have extensive international experience (lived in West Africa for two years) and I speak Portuguese fluently. I am an experienced leader
through years of service in professional and volunteer organizations. My training and background allows me to interface with
colleagues from multiple disciplines; computer scientists to engineers, and biologists to entrepreneurs.
“With experiences in the development of policy for nonprofit organizations, I am relentless
in the pursuit of improving the bioeconomy in my own community, as well as in global
populations.”
I served as the president for Beta Beta Beta, National Biological Honor Society, where I designed a program that demonstrated the interface between science and different disciplines, such as politics, economics, and psychology, to drive biomedical
progress. Integration of leadership and consultation experience, in the development of health policy initiatives for public
education, has led to opportunities to present at the Association for Community Health Improvement Conference, an
internship at Innovative Funding Partners, and membership in Omicron Delta Kappa National Leadership Honor Society.
Melody Cheng, PhD
Postdoctoral Research Scientist
Kimbell Duncan
MS, Biotechnology Candidate
Columbia University Medical School
Focus: Biomedical Research
Georgetown University
Focus: Biomedical Research
“7+ Years Accomplished Human & Mouse Neural Stem Cell Scientist | Goal Oriented Team
Leader & Marketer | Passionate about Problem Solving.”
“As a scientist and a consultant, I create systematic strategies to solve each problem”
• Developed research approaches in various challenging fields ranging from cancer to brain diseases; published collaborative
work in leading scientific journals, including Science (world’s top 2) & PNAS, which facilitated 60+ global publications in 3 years.
• Led a 7-PhD team to initiate the Career Development Course to outreach to government and Fortune 500 companies,
to build up academic-industry relationships, and to guide 250+ PhDs in career planning; the course series was co-awarded
$200K to establish a new career center and internship programs.
“
10
“The remaining part of my professional career and the bulk of my philanthropic activities will
be dedicated to improving the lives of the poor, under-educated and infirm by developing and
facilitating access to novel technologies.”
Mr. Duncan has 27 years experience in the investment business. Beginning his career at Goldman, Sachs & Co. in 1987, he
also worked for Nomura International, Credit Suisse (Europe) and Mizuho International leading teams conducting principal
investment activities for the firms. He is an active angel investor and sits on the boards of PepTCell Limited, Pharmajet Inc,
inFirst Healthcare Ltd., Curemark LLC, Curelon LLC and Spatial View Inc. He co-founded the Rush Foundation in the UK and
founded the Rush Charitable Foundation in the U.S. He is currently pursuing a Masters of Science degree in Biotechnology at
Georgetown University.
Meet the 50 Leaders of Tomorrow
11
12
Jacquelyn Duvall
PhD Candidate
Joe Francica, PhD
Postdoctoral Fellow
University of Virginia
Focus: Biomedical Research
NIH
Focus: Biomedical Research
“I’m passionate about explaining complex scientific ideas to non-scientists and helping others
understand the importance of innovation. For future pursuit, I’m interested in patent law and
scientific editing.”
As a graduate student, I have had the opportunity to participate in several great entrepreneurial endeavors. In 2014, my
advisor and I filed a provisional patent on my current research, focused on the development of a novel, label-free detection
modality with biodefense and infectious disease applications. Working with another graduate student in the same lab, we
have helped develop the technology that serves as the basis for a start-up company out of the University of Virginia.
“Passionate about improving public health through vaccination and collaborative by nature, I
am an entrepreneur looking to deepen professional ties across the region.”
Dr.. Francica was trained as a microbiologist at the University of Pennsylvania, where he completed his thesis on Ebola virus
cellular pathology. He then began a fellowship at NIH where he worked with Novartis to evaluate the ability of next generation
adjuvant formulations to induce immune responses to HIV. He was awarded the Fellows Award for Research Excellence in
2012 and led the NIH science policy interest group. Recently Dr.. Francica co-founded Avidea Technologies to develop a novel
vaccine delivery technology for cancer and infectious diseases. He looks forward building Avidea into a successful biotech in
the Mid-Atlantic region.
Steve Marquis Fernandes
Laboratory Manager
Tyler Gable
Graduate Research Assistant
Johns Hopkins Medical Institute
Focus: Biomedical Research
University of Maryland, Baltimore
Focus: Biomedical Research
“To work out an impossible scientific scenario milestone is a challenge, the craze to finish
before the deadline excites me the most. Project Manager (Therategist) within pharmaceutical
& biotechnology ventures.”
My diverse scientific publications reflect the essence of cross-functional team work. As a program manager for LIDPEG, an
innovative challenge within a team of glyco-scientists is to spur curiosity in understanding biochemical mechanisms for
Asthma and COPD. To “think out of the box” is an asset that I leveraged at the 2014 Merck Innovation cup, Germany. My
technical and business background proved instrumental in winning the Merck Innovator Award 2014. As a team, our technical
solutions fitted to the current and future of big pharma Merck’s architecture roadmaps and blueprints. My goal is to influence
our next generation of visionaries.
“I seek to surround myself with fellow smart-creative individuals and be a leader of industry in
the pursuit of progressive, creative and revolutionary biomedical science.”
I don’t want to become complacent and I don’t want to just let life happen. I strive for continuous personal growth and
evolution of my character. I chose to pursue my PhD at the University of Maryland, Baltimore because I wanted to learn how
to think critically and progressively about biomedical science. I have continuously pursued skills of leadership and entrepreneurship with which I strive to accomplish my potential as a scientist and one day perhaps as a leader of business.
Meet the 50 Leaders of Tomorrow
13
14
Curtis Gallagher
Graduate Research Assistant
John Goertz
PhD Candidate
University of Maryland, Baltimore
Focus: Biomedical Research
University of Maryland
Focus: Biomedical Research
“Life Sciences PhD with electrophysiology expertise and an extensive medical/pharmacy
background. I’m passionate about new medical and scientific technologies and have a talent
for idea generation and creative approaches to regulatory/administrative roadblocks.”
Extensive nine year background in various pharmacy settings and clinical research. Six years of basic science laboratory
experience as a PhD Graduate Research Assistant including patch-clamp electrophysiology, FRET, protein chemistry, and
confocal imaging. Created, secured administrative/regulatory approvals for, and currently run a software startup. Longstanding rapport with UMB Tech Transfer Office through several invention disclosures and exposure to regulatory science
through work with the FDA Chief Scientist & MedWatch team. Experience establishing positive working relationships with/
acting as a valuable resource for clinicians, researchers, faculty, administrators, entrepreneurs, and investors. Well-versed in
scientific, medical, pharmacy, business, biotechnology, and intellectual property concepts.
“Smartphone-enabled aptamer diagnostics for rural medicine: extending the reach of
healthcare to create a preferential option for the poor.”
Having earned degrees in Physics and Cell & Molecular Biology, I am currently pursuing a Ph.D. in Bioengineering. As a
Fischell Fellow in the White Lab, I am working towards the development of low-cost, portable diagnostic devices for pathogen
detection and disease monitoring. While medical science continues to improve greatly, the benefits of such growth often
leave behind a large sector of our society for whom cutting-edge technology remains unaffordable or inaccessible. I combine
the ubiquity and compact power of the smartphone with the flexibility and affordability of aptamer technology to design
diagnostic devices to help bridge that gap.
Andrew Geltman
Government Affairs Graduate Fellow
Sean Gugerty
Third Year Law Student
Maryland Law/Merck & Co., Inc.
Focus: Health Law
University of Maryland Carey School of Law
Focus: Law
“I am not just highly educated, articulate, a good team player or a hard worker. I am a fun
person and an avid baseball fan, Go Nats! ”
“Health Law Student at the University of Maryland Carey School of Law interested in health IT,
privacy, and other emerging health care regulatory issues.”
I am a highly motivated, soon to be law graduate with practical and academic training in politics, government and law.
As an undergraduate I was a student leader and government major. While still in college, I worked on two major political
campaigns. As a law student, I engaged with government entities as a research assistant for a non-profit consulting firm and
as a government affairs graduate fellow for Merck & Co., Inc. Lastly, I specialize in Health Law and serve as an editor on the
Journal of Health Care Law & Policy, in which I have a publication on antibiotics.
A 3L student at the University of Maryland Carey School of Law, focusing on health care law. Member of the Maryland Moot
Court Team, and the Journal of Health Care, Law, & Policy. Participated in numerous internships and clinical law opportunities, including at Johns Hopkins Legal Department, HHS Office of the General Counsel, the Maryland Court of Appeals, and
the University of Maryland Public Health Law Clinic. Prior to law school, worked at a health IT consulting start-up. Following
graduation, Sean will be the Judicial Law Clerk to the Honorable Sherrie R. Bailey in the Circuit Court for Baltimore County.
Meet the 50 Leaders of Tomorrow
15
16
Jessica Harakal
PhD Candidate
Katie Howell PhD
Postdoctoral Fellow
University of Virginia
Focus: Biomedical Research
Integrated BioTherapeutics
Focus: Biomedical Research
“A passionate, creative, and analytical research scientist interested in using my expertise in
immunology to develop novel therapeutics in a challenging, team-oriented environment.”
My dissertation research focuses on investigating regulatory T cells and mechanisms of autoimmunity. I was awarded an
NIH Immunology Training Grant and have experience managing collaborative projects and communicating results to various
audiences. I enthusiastically promote science through mentoring undergraduate students and volunteer opportunities,
including reviewing manuscripts written by middle and high school investigators. As the co-founder and president of an
American Society for Microbiology student chapter I led scientific outreach events. Currently, I volunteer on an interdisciplinary team consulting for a local non-profit. Professionally, I am interested in pursuing a career in research and development
within a biotechnology company.
“Katie is a results-driven, infectious disease Post-doctoral Fellow with an entrepreneurial
spirit. She is eager to engage in a dialogue that will result in creative solutions for science and
healthcare.”
Katie is currently a Post-doc at Integrated BioTherapeutics, researching a Pan-Filovirus vaccine or therapeutic to target Ebola,
Sudan and Marburg. She received a B.S. in Biochemistry at Temple University, and a Ph.D. in Molecular Microbiology and
Immunology at the Institute of Human Virology at the University of Maryland, Baltimore. She also interned at the Office of
Technology Transfer at the University of Maryland and at the White House’s Office of Science and Technology Policy (OSTP). At
OSTP she worked with the President’s Council of Advisors on Science and Technology (PCAST) to make science policy recommendations to President Obama.”
Sam Hong
PhD Candidate
Po-Yuan Hsiao
PhD Candidate
Johns Hopkins University
Focus: Biomedical Research
Johns Hopkins School of Medicine
Focus: Biomedical Research
“Chemical Biology PhD Candidate from Johns Hopkins University with varied background
in drug development seeking high impact opportunities in all aspects of biotech. Inventive,
Motivated, Driven by challenges. ”
“Excellent interpersonal skills with strong leadership instincts and scientific expertise / Enjoys
tackling complex problems, especially in a team-oriented environment / Looking for strategic
roles within management consulting or the biopharma industries.”
5th year Chemical Biology PhD candidate at The Johns Hopkins University in the laboratory of Dr.. Jun O. Liu. Developed a
45,000 member Rapamycin-based macrocycle library and screening platforms. Designed silica gel based library purification,
solvent evaporation, and semi automated weighing platform. Identified isoform-specific low-nanomolar inhibitor of human
equilibrative nucleoside transporter 1. Skills attained: small molecule macrocycle chemistry, library design, solvent concentrator fabrication, high throughput screening, cell culture, target identification, membrane transporter biology. 8 peer reviewed
journal publications. Assistant faculty in Faculty of 1000 under Dr.. Larry K Keefer. Director of External Relations in the Hopkins
Graduate Consulting Club
I am a Ph.D. candidate studying Pharmacology at the Johns Hopkins School of Medicine. My biomedical research experiences have centered on various drug delivery platforms, for example: (1) functionalized nanoparticles for targeted chemotherapy, (2) peptide-based inhibitor design for diabetes and obesity, and (3) protein-small molecule conjugates for cancer immunotherapy. In addition to scientific research, I also have a strong passion for entrepreneurship and management consulting. My
previous consulting experiences include developing strategic recommendations in portfolio management, market access, and
operations for leading multinational clients in the pharmaceutical, biotech, and medical device industries.
Meet the 50 Leaders of Tomorrow
17
18
Janet Li
Project Manager; Masters Student
Kunal Parikh
PhD Candidate
Georgetown University
Focus: Biomedical Research
Johns Hopkins University
Focus: Biomedical Research
Janet is currently pursuing her M.S. in Biostatistics at Georgetown University while working as the project manager for the
VICTORS Project, an NIH funded study to verify information and communication technology and outcomes research in stroke.
In 2011, she was awarded Duke University’s Dean’s and Civic Summer Research Fellowships to investigate the impact of rural-to-urban male migration on women in rural Udaipur, India. It was during her time in Udaipur when she first developed
an interest in quantifying healthcare challenges to improve health. In her spare time, Janet loves to read Murakami, watch
Bollywood films, explore museums, and drink tea.
“Aligning technology development, (social) enterprise, and transformative public policy to
create a world where no person is limited by the circumstances of their birth.”
Kunal Parikh is an NSF Fellow and Roche Scholar working at the interface of science and translation in the Johns Hopkins
University School of Medicine’s Center for Nanomedicine and in the Biomedical Engineering Department’s Center for Bioengineering Innovation and Design. From 2012-2014, he built and served as the Executive Director of The Social Innovation Lab,
an incubator for social enterprises where he advised and mentored dozens of mission-driven entrepreneurs. Previously, he
served as the founding CEO of Core Quantum Technologies, a startup biotechnology company developing superior imaging,
detection, and targeting reagents.
Roger Lin, MD, PhD
Founder/CEO
James Pitcavage
PhD Candidate
Ultraviolet Interventions, Inc.
Focus: Medical Device Development
Pennsylvania State University
Focus: Health Economics
“Shining a new light on an old problem.”
“I am working on hiking to the highest point in each of the 50 states. ”
Roger Lin, MD, PhD is a biomedical engineer and radiologist who founded Ultraviolet Interventions to address the difficulty
with managing catheter infections in dialysis patients. Ultraviolet Interventions uses disposable UV light-emitting optical
fibers to kill bacteria within a catheter’s lumen while the catheter remains implanted in a patient.
I am a PhD candidate in the department of health policy and administration at Penn State. I am also a health economist with
Geisinger Health System. My work focuses on the impact of technology adoption including cost-effectiveness of biomarker
diagnostic tests, use of biologics, and genetic tests. I coordinate work with pharmaceutical companies related to assessment
of medication adherence, cost-effectiveness and patient outcomes.
He obtained both his MD and Biomedical Engineering PhD, with a focus in biomedical optics, from Case Western Reserve
University. He completed his radiology residency at University Hospitals Case Medical Center. He obtained his bachelor’s
degree from Duke University, majoring in Biomedical Engineering, Electrical Engineering, Physics, and Computer Science.
I have experience in economic modeling, health policy, and conducting patient centered research. I also support research
using multi-criteria decision analysis to assist decision makers in assessing the impact of new technologies on health outcomes
and costs.
Meet the 50 Leaders of Tomorrow
19
20
Varun Vijay Prabhu
PhD Candidate
Anand Ravindran, PhD
Postdoctoral Fellow
Pennsylvania State University
Focus: Biomedical Research
MedImmune
Focus: Biomedical Research
“Active student leader: worked on initiatives for career development, multicultural awareness
and campus diversity, raising funds for charity and social causes. Currently seeking postdoctoral fellowship opportunities in industry or academia.”
“I want to be a future scientific entrepreneur to improve patient healthcare by integrating innovative technology solutions to address complex challenges in the rapidly evolving
biomedical field.”
Research scientist in the field of oncology drug discovery committed to translating findings at the bench to improve cancer
therapy for patients. Co-authored several peer-reviewed publications exploring preclinical cancer therapeutics, cancer cell
death, p53 pathway restoration and targeting therapy-resistant cancer stem cells. Worked with the drug discovery company
Oncoceutics, Inc for lead identification and optimization of the therapeutics pipeline, international grant applications to
expand R&D efforts and filing disclosures of intellectual property. Diverse training in skills essential for an independent
scientist - Ability to multi-task and work collaboratively on team-based projects
I am an experienced, self-motivated researcher with a strong passion for translational research. My primary area of interest
is identification of novel drug targets based on an in-depth understanding of disease mechanism and generating companion
biomarkers for inflammation associated pathologies such as cancer and autoimmune diseases. My doctoral training in ImmunoOncology focused on the tumor-promoting role of chronic inflammation. My current project at MedImmune focuses on
targeting the crosstalk between cancer stem cells and anti-tumor immune response for designing durable immunotherapeutics. I have also actively participated as a student representative in the Society of Toxicology for Dermal Toxicology and Immunotoxicology specialty interest groups.
Ferdinando Pucci, PhD
Postdoctoral Fellow
Stephen Restaino
PhD Candidate
Massachusetts General Hospital
Focus: Biomedical Research
University of Maryland, College Park
Focus: Biomedical Research
“I am formulating a vision of cancer development that I hope to transform into a business idea
for a start-up biotech company.”
“I am highly motivated to improve sensing technologies for a range of biomedical applications,
primarily highly sensitive systems with high portability and low cost.”
Trained in pharmaceutical chemistry, I delved into molecular mechanisms of cancer immunology and opened my way through
with biotech tools I developed and validated. I gained leadership expertise by serving the postdoc association and by cofounding a science promotion association for lay audience, for which I contribute as scientific editor. I am passionate about
Science with a zeal for reproducibility. Currently, I am learning how to be mindful of translation opportunities.
Throughout my academic career, I have dedicated my time to biomedical research and its applications to global health. As
an undergraduate, I working in a Soft Tissue mechanics lab, researching material properties of insect tracheal tubes for soft
material fluidic applications. I also dedicated a significant amount of time to starting a chapter of a Engineering World Health,
which is dedicated to solving engineering related biomedical issues in low resource areas. I also spent time with Engineers
Without Borders travelling to the Dominican Republic to repair a water treatment system for a school and clinic. After
graduating with my bachelors, I took a one year research internship at the FDA, where I studied and published on the acute
functional and mechanical impacts of peripheral nerve implants.
Meet the 50 Leaders of Tomorrow
21
22
Summer Rozzi
PhD Candidate
Eugene Shenderov, MD, PhD
Resident Physician
Georgetown University
Focus: Biomedical Research
Johns Hopkins University
Focus: Medicine
“I’m passionate about the easy and accurate public consumption of science. I’ve worn many
hats in my career - academic, educator, writer, and leader. As a result, I have a unique ability
to manage multi-faceted projects and develop creative solutions to challenges.”
“Physician-scientist and Rhodes Scholar striving to develop the next generation of cancer
therapies and provide leading edge healthcare for all. Energized to collaborate with individuals transforming medicine and biotechnology.”
My excellence in the laboratory has been rewarded with the funding of an Individual National Research Service Award. Additionally, I received the highest awarded Early Career Investigator Award from the Society for Neuroimmune Pharmacology
for my work investigating neurotoxic mechanisms of HIV-1 Tat on mitochondria. Beyond the laboratory, I am actively directing
courses, volunteering in local schools, and serving in the leadership of various organizations. As President of the Medical
Center Graduate Student Organization (MCGSO), I have helped to expand the number of academic and professional opportunities available to graduate students at Georgetown, including a reinvigorated Student Research Day.
As physician-scientist, Eugene Shenderov focuses on addressing the challenges facing society to provide leading edge
healthcare for all. A Rhodes Scholar with an MD/PhD from the Johns Hopkins University School of Medicine, National Institutes
of Health and University of Oxford, he has worked at the bench harnessing cancer immunotherapy. Now, in the clinical arena,
he is working to translate discoveries from the bench to the bedside and the reverse. By founding Charm City Clinic, Inc., a
501(c)(3) non-profit organization, he is advancing health care access for low-income residents of Baltimore.
Seila Selimovic, PhD
Science and Technology Policy Fellow
Daniel Shu
Pharmacy Analyst
AAAS / U.S. Dept. of State
Focus: Policy
Adventist HealthCare
Focus: Pharmacy
“Bioengineer / physicist / science policy expert: Developing smart healthcare technologies for
drug screening, point-of-care diagnostics, and personalized medicine”
“Even though I’m still in school, I hope to improve healthcare through entrepreneurship and
innovation. “Don’t let schooling interfere with your education.” – Mark Twain”
Dr.. Selimovic is an innovative physicist / bioengineer with over ten years of research experience and a record of leading multidisciplinary groups to solve cutting-edge technical challenges and deliver novel solutions for drug screening and bioengineering studies. As a Research Fellow at Harvard Medical School she secured over $1.5 million in grant revenue, and has published
over 60 research articles and editorials and presented at 40 national and international meetings. Her R&D interests include
tissue engineering, microfluidics, lab-on-a-chip and organ-on-a-chip, and high-throughput screening solutions. As a AAAS
S&T Policy Fellow, she is interested in innovation, public-private partnerships and scientific cooperation.
Daniel Shu is currently a pharmacy student at the University of Maryland School of Pharmacy. In addition to being in school,
Daniel is currently an analyst at Adventist HealthCare, working with clinical leaders to support the P&T committee. He is also
working on developing a medical device with an interdisciplinary team under the leadership of Dr.. Scott Strome, Chair of
UMB Otorhinolaryngology. His research experience includes working in analytical development at TEVA Biopharmaceutics,
and also in Dr.. Paul Meltzer’s cancer genetics lab at the National Cancer Institute. Prior to starting school, Daniel completed a
global marketing internship at Nasdaq.
Meet the 50 Leaders of Tomorrow
23
24
Jan Sieluk
PhD Candidate
Elisabeth Lily Sooklal
Biotech Director
University of Maryland School of Pharmacy
Focus: Pharmacoeconomics
Startup Shell
Focus: Biomedical Research
“Proactive and goal-oriented. Interested in Pharmacoeconomics; CEA; CER; HRQoL; cost &
utilization analyses; cost containment strategies; Evidence-Based Medicine; clinical trials;
pediatric vaccines. Looking for opportunities to work in pharmaceutical industry.”
Jan is a pharmacist from Warsaw, Poland who graduated from Medical University of Warsaw in 2013. He currently serves as
a graduate research assistant for Professor C. Daniel Mullins, PhD and Peter Doshi, PhD. Jan is also the Business Manager of
the University of Maryland International Society of Pharmacoeconomics and Outcomes Research (ISPOR) student chapter.
Before joining the PHSR graduate program at the University of Maryland, Jan worked for GlaxoSmithKline and owned his own
consulting company based in Europe in which he finalized projects for key European players in the pharmaceutical, hospital
and insurance markets.
“Bioengineer, female founder, startup mentor: I create badass medical devices in immunology
and diagnostics”
Currently, I am the biotech Director of Startup Shell where I spearheaded the expansion and diversification of this startup
incubator. I am a co-founder of the biotech startup MedPrint. In addition, I am a biomedical researcher at the University of
Maryland where I produce simple assay and microfluidics based testing, using extremely small patient samples, for quick
diagnosis of a disease or array of diseases. I have a patent on a nanoscale chemistry that allows for faster breast cancer
screening and am passionate about creating medical devices that will revolutionize global health.
Kelley Smith
MBA Candidate
Kelsey Stafstrom
Masters Student
Johns Hopkins University/NIH
Focus: Business and Management
Georgetown University
Focus: Biomedical Policy and Advocacy
“I like answering questions as accurately as possible – and it is always possible to improve
accuracy.”
I am a current MBA Candidate at Johns Hopkins University, a graduate of Vanderbilt University with a B.A. in Economics, and
have been employed in Management Analyst, Program Analyst, Grants Management Specialist, and auditing roles in a federal
capacity. Compared with my peers, I am told that I am resilient to setbacks, naive and curious about new things to learn and
their applications, and have a growth mindset (possible reasons for that conclusion may be that I founded a start-up at 22,
work full time for the government, and enrolled in the Johns Hopkins University MBA program at the age of 24 following 3
years of full-time work experience). These attributes help me solve problems creatively.
“My goal is to integrate scientific findings with evidenced based policy and programming. My
primary focus is on stabilizing the global imbalance of the burden of disease through these
policies.”
As a research scientist at Salve Regina University, I had the opportunity to lead a cancer genetics project elucidating a nutraceutical alternative treatment to gastric adenocarcinoma. The project was shared at international conferences and through
these meetings, I quickly found an interest in science communication and interdisciplinary collaboration. I am currently
earning my Masters degree in Biomedical Science Policy and Advocacy at Georgetown University with the goal of creating
avenues for communication at the intersections of health, science, politics, and the public agenda.
Meet the 50 Leaders of Tomorrow
25
26
Sharlene Su
M.D. Candidate
Maggie Swierczewska, PhD
Postdoctoral Fellow
University of Maryland School of Medicine
Focus: Medicine
Johns Hopkins University
Focus: Biomedical Research
“M.D. candidate and former Google employee with a diverse public health background seeking
to develop novel technologies to streamline and innovate the practice of patient-centered
healthcare”
Sharlene is a medical student at the University of Maryland and formerly a medical consultant at Mango Health, a health
technology startup partnering with hospitals to improve medication adherence by using the concept of gamification. She
previously worked at Google to develop Google Health and global payments infrastructures.
With a B.A. in Public Health from Johns Hopkins University, Sharlene has researched child mortality at the W.H.O. and implemented health programs in Ghana and Baltimore. She aspires to integrate medicine and technology to empower patients with
knowledge and create a nimble, safe, and cost-effective model of healthcare delivery.
“A PhD biomedical engineer energized to contribute credentialed research skills and passion to
the MD bioeconomy.”
Maggie has not been afraid of challenges. As a graduate student, she initiated an individual partnership with NIH to being
her predoctoral studies within an interdisciplinary setting at NIBIB/NIH. There she gained expertise in nanotechnology, drug
delivery and theranostics. After successfully defending her doctoral thesis in December 2012, Maggie started a postdoctoral
fellowship at Johns Hopkins University to continue her training in cancer-targeted theranostics. She has built up an extensive
research publication record so far with over 700 citations. In addition to sharing science, her interests strongly lie in translating science into tangible biomedical solutions. Maggie is also a co-founder of a MD-based biotech start-up where she manages
programs for two lead therapeutic compounds and promotes fundraising. Maggie continues to take on new challenges and is
ready to make an impact to this incredible region and beyond.
Yuanming Suo
PhD Candidate
Jeffrey Teoh
PhD Candidate
Johns Hopkins University
Focus: Machine Learning
University of Virginia
Focus: Biomedical Research
“Data Ninjas, Medical Device Entrepreneur, Management Consultant”
My Ph.D. research is developing machine learning algorithms for biomedical applications. So far, my work has resulted in 20
journal and conference papers, and one Best Student Paper Award. In 2010, I co-founded a wearable medical device start-up.
Within four years, I won six business plan competitions and secured $1.5MM investment with our prototype, pending approval
by the China Food and Drug Administration. As co-president of the Hopkins Graduate Student Consulting Club, I have led
pro-bono consulting projects, serving a wide range of clients, including start-ups, a non-profit organization, and multinational
companies. This fall, I will join McKinsey & Company
“With enthusiasm, big picture focus, and an open ear for great ideas, I find ways to turn those
ideas into real products and services.”
I am a senior PhD candidate in Microbiology and Immunology with a high energy for managing projects, creating partnerships, and advancing goals beyond the status quo. My thesis work addresses how our genetics influence susceptibility to
infection, and in turn, how they impact long-term immunity. This will inform considerations for future vaccine developments
and treatment options. In addition to my training in immunology and infectious diseases, I have experience leading teams,
coordinating committees, and fostering inter-organizational collaborations. I am also an avid runner, and having completed
four marathons, the virtues of hard work, determination and patience are all well engrained.
Meet the 50 Leaders of Tomorrow
27
28
Michael Vinluan, MD
Law Student
Tianjiao Wang, PhD
Research Fellow
University of Maryland Carey School of Law
Focus: Law
University of Michigan
Focus: Biomedical Research
“A medical doctor and future lawyer who believes that growing is a choice to renew yourself,
based not on your limits but on your vision.”
With a medical degree, Michael Vinluan is pursuing his Juris Doctor degree to focus on how law and medicine can advance
together. Michael currently serves as an intern at the Food and Drug Administration, and a medical-legal consultant for law
firms. He previously served as a law clerk at the Johns Hopkins Hospital.
Prior to law school, Michael worked for Centers for Disease Control and Prevention contracts where he conducted complex
clinical and technical consultations regarding critical health threats, outbreaks, and bioterrorism.
Michael is a member of the American College of Legal Medicine, and the Food and Drug Law Institute.
“A biomedical scientist specialized in aptamers, cancer and diagnostic/therapeutic development with awards of a small Business innovation research grant from NIH and Abstract
Achievement Award from American Society of Hematology.”
I am a biomedical scientist with expertise and experience in aptamers, cancer biology, biomarker discovery and validation,
diagnostic and therapeutic development. I developed an aptamer-based biosensor prototype for early diagnosis of acute
kidney injury, developed small molecules and aptamer drug leads against ebolavirus protein and identified a novel subset
of T-cell lymphoma with distinct molecular and clinical features by molecular profiling. In recognition, I was awarded a small
Business innovation research grant from NIH, Abstract Achievement Award from American Society of Hematology twice and a
Young Investigator Award from Cutaneous Lymphoma Foundation.
Phi Vu, JD
DOD Program Manager
Zhikui (Zeke) Wei, PhD
M.D. Candidate
DOD; Maryland Law
Focus: Biomedical Research
Johns Hopkins University School of Medicine
Focus: Medicine
“Forward thinker that applies a multi-disciplinary approach to identify and address new
challenges. In constant pursuit of good food, good people, and good snow.”
“Physician scientist in training at Johns Hopkins interested in developing innovative next
generation therapeutics for diabetes and metabolic diseases”
Phi possesses over ten years of professional experience in U.S. government, private industry, and academic research organizations. He currently supports the Department of Defense’s Joint Project Management Office for Medical Countermeasures
Systems utilizing his academic and professional background in law, biodefense, biotechnology, public health, and national
security to provide policy and acquisition management for the DOD’s Chemical and Biological Defense Program. He prides
himself on his ability to apply legal and scientific principles to research, analyze, and solve problems to inform policy and
decision support at the federal government level (DOD, HHS, DHS, U.S. Congress).“
•
Basic scientist well published in the adipokine and metabolic research who was the first to identify and characterize
adipokines CTRPs 11-13
•
Research was highlighted in high impact scientific media, including SciBX and Global Medical Discoveries
•
Research was recognized at major conferences such as Keystone Symposia on obesity and diabetes
•
Research attracted a industrial grant from a leading pharmaceutical company in diabetes care
Meet the 50 Leaders of Tomorrow
29
30
Margaret Wierman
PhD Candidate
Nicolas Wyhs, PhD
Postdoctoral Fellow
University of Virginia
Focus: Biomedical Research
Johns Hopkins University
Focus: Biomedical Research
“Tackling trillion cell problems one single-cell eukaryote at a time.”
As a senior PhD student, I’ve spent my graduate career combining various fields such as bioinformatics, metabolomics, and
classical yeast genetics to elucidate common molecular causes of aging and identify practical interventions for prolonging
healthspan. The breadth of scientific expertise my academic pursuits have required has given me extensive training in bridging
technical fields and coordinating cross-specialty collaborations. It is, therefore, my belief that only through harnessing our
communal expertise can we find solutions to problems that are not only scientifically consistent but economically sound and
socially relevant.
“Post doctoral fellow in oncology looking for new opportunities in biotech or big pharma in the
fields of oncology and pharmacology.”
Post-doctoral fellow in the Ludwig Center at Johns Hopkins University looking for exciting opportunities in biotech and big
pharma in the fields of oncology and pharmacology. Successfully led a project at a biotech company as a research associate
to find a gene expression based signature for colorectal cancer prognosis. Gained experience with drug discovery and lead
identification and validation while investigating novel small molecule inhibitors for an epigenetic reader protein. Also have
experience using next generation sequencing as a tool for DNA as well as methylated DNA and RNA analysis.
Shannon Wongvibulsin
MD/PhD Candidate
Jing You
PhD Candidate
Johns Hopkins University
Focus: Biomedical Research
Johns Hopkins School of Medicine
Focus: Biomedical Research
“Revolutionizing medicine and shaping a healthier tomorrow through preventive health
education, innovation in biomedical engineering, and synergy as a physician scientist.”
“Highly initiated/ Personalized genomics & Individualized healthcare & Technology commercialization / Strong management and analytic skills/ pro-bono healthcare consulting ”
Shannon Wongvibulsin is a first year student at Johns Hopkins’ Medical Scientist Training/MD-PhD Program. She graduated
summa cum laude from UCLA with degrees in bioengineering and biomedical research. At UCLA, she performed research on
scaffold fabrication for tissue engineering purposes. She was also the Director and Editor-in-Chief of UCLA Student Wellness
Commission’s Total Wellness Magazine. At Hopkins, she leads the Nutrition in Medicine Interest Group as well as the Student
Wellness Initiative Physical Health Committee. Her current interests include biomedical engineering and public health. More
specifically, she is passionate about developing biomedical technology for disease management and prevention.
Jing You is a PHD candidate in Dr. David Valle’s lab in Baylor-Hopkins Center for Mendelian Genomics. Her research focused on
using genomic sequencing technologies to identify novel diseases genes for Mendelian disorders. She is a technology driven
person with strong management and problem solving skills in healthcare industry. She worked as a pro-bono consultant in
Carey Net Impact in Johns Hopkins Carey Business School in healthcare branch. Recently, she joined Rare Genomics Institute
as a project manager to leverage her expertise in genomic sequencing to help rare disease patients for potential cure and also
initiating international collaborations.
Meet the 50 Leaders of Tomorrow
31
Tao Yu, PhD
Hatteras Discovery Fellow
32
Our Volunteers
Hatteras Venture Partners
Focus: Venture Capital in Healthcare
“Tao is passionate in bridging science with business to create value/impact. He is a Hopkinstrained bioengineer and a McKinsey offeree, with exceptional leadership and experiences in
venture capital and consulting.”
NourAl-muhtasib
PhD Student
Georgetown University
Karina Bora de
Oliveira, PhD
Postdoc MedImmune
Sarah Conley, PhD
Postdoc
MedImmune
Gabriela Marchetti, PhD
Postdoc
MedImmune
Ricardo Silva, PhD
Postdoc
MedImmune
Yebin Zhou, PhD
Postdoc
MedImmune
Tao is a recipient of the Hatteras Discovery Fellowship, a distinguished opportunity for Ph.D. talents who are passionate about
venture capital in the healthcare sector. Prior to Hatteras, Tao worked as an intern at BioHealth Innovation, and completed
his Ph.D. in Biomedical Engineering at Johns Hopkins. He co-authored 24 journal articles/conference proceedings, including a
Nature Materials cover-featured article, and 3 patent applications. At Hopkins, he led multiple community/career initiatives as
President of the Chinese Students and Scholars Association and Director of Communications of the Graduate Consulting Club.
Tao received his B.S./B.Econ. as a Distinguished Graduate from Peking University in 2008.
Our Advisory Board
Bahija Jallal, PhD
MedImmune
Mickey Kim, MD, MBA Phil Cole, MD, PhD
MedImmune
Johns Hopkins
School of Medicine
Yuling Li, PhD
MedImmune
33
Keynote Speakers
Pascal Soriot
Executive Director and Chief Executive
Officer, AstraZeneca
Marc Tessier-Lavigne, PhD
President, Rockefeller University
Panelists continued
Gerd Binnig, PhD
Nobel Laureate, Founder and Chief
Technology Officer, Definiens
Panelists
Bill Petri MD, PhD
Alan I. Leshner, PhD
Josh Henkin, PhD
Michael J. Friedlander, PhD Richard A. Williams, PhD
Chief, Division of Infectious Diseases
& International Health, University
of Virginia School of Medicine
Program Manager, The Tauri Group; Board
member, National Postdoctoral Association; Career Coach and Entrepreneur
Chief Executive Officer Emeritus,
American Association for the Advancement of Science (AAAS)
Executive Director, Virginia Tech Carilion
Research Institute; Associate Provost
for Health Sciences, Virginia Tech
34
Syed Khalid
MD student and researcher, Hopkins Neuroscience; Young Entrepreneur; HHMI Fellow;
Founder and Chief Executive Officer, NexPil
Vice President, Policy Research, Mercatus
Center at George Mason University
Gene G. Olinger,
Jr., PhD, MBA
Justin Hanes, PhD
Andreas Seiter, MD
MRI Global Contractor, NIAID, NIH
Lewis J. Ort Endowed Professor of Ophthalmology; Director of the Center for Nanomedicine, Johns Hopkins University School
of Medicine; Founder, Graybug, Kala
John Finkbohner, PhD, RAC
Ronald Bailey
Robert Graboyes, PhD
Thomas P. Caruso,
PhD, MBA, PMP
Sara Nayeem, MD, MBA
Ivor Royston, MD
Senior Regional Policy Director, AstraZeneca
Health Informatics Liaison, University
of North Carolina at Chapel Hill
Science Correspondent, Reason Magazine
Principal, New Enterprise Associates
Senior Health Specialist – Pharmaceuticals, The World Bank Group
Senior Research Fellow, Mercatus
Center at George Mason University
Founding Managing Partner,
Forward Ventures
35
Panelists continued
36
TUESDAY SCHEDULE
7:30 - 8:00 AM
ARRIVAL: REGISTRATION AND BREAKFAST
Main Atrium
8:15 - 8:30 AM
WELCOME REMARKS
Main Atrium
Marina Carla Cabrera, PhD President, Leaders of Tomorrow Summit
8:30 - 9:30 AM
Michael Weingarten, MA
Director, SBIR and STTR Programs,
National Cancer Institute
Kevin Owen, PhD
Chief Operating Officer,
Rivanna Medical
Culturing Next-Gen Leaders for Tomorrow’s Bioeconomy
Main Atrium
Moderator:
Jianqing “JQ” Li, PhD COO, Leaders of Tomorrow Summit
Christian Plaza, JD
Emily Billings Speaker Liaison Director, Leaders of Tomorrow Summit
Partner, Cooley LLP
Panelists:
Alan I. Leschner, PhD Chief Executive Officer Emeritus, American Association for the
Advancement of Science (AAAS); Executive Publisher of the journal Science
Bill Petri MD, PhD Chief, Division of Infectious Diseases & International Health,
University of Virginia School of Medicine
Syed Khalid MD student and researcher, Hopkins Neuroscience;
Young Entrepreneur; HHMI Fellow; Founder and Chief Executive Officer, NexPil
Josh Henkin, PhD Program Manager, The Tauri Group;
Board member, National Postdoctoral Association; Career Coach and Entrepreneur
Bahija Jallal, PhD
Executive Vice President, AstraZeneca, Head of MedImmune
Drew Pardoll, MD, PhD
Michael J. Friedlander, PhD Executive Director, Virginia Tech Carilion Research
Institute; Associate Provost for Health Sciences, Virginia Tech
Harriet Fear
Professor of Oncology, Medicine, Pathology, Chief Operating Officer, One Nucleus UK
Molecular Biology, and Genetics; Director,
Cancer Immunology Program, Johns Hopkins
University; Founder, Amplimmune
9:40 - 10:00 AM
PLENARY: THE IMPORTANCE OF THE MD/DC/VA REGION TO GROWING
COMPANIES: AN AZ PERSPECTIVE
Main Auditorium
Pascal Soriot, Executive Director and Chief Executive Officer, AstraZeneca
10:00 - 10:30 AM
KEYNOTE: ACADEMIC - INDUSTRY PERSPECTIVE PLENARY
Main Auditorium
Marc Tessier-Lavigne, PhD, President, Rockefeller University
10:30 AM
Steve Ferguson, MS,
MBA, CLP
Deputy Director, Licensing and Entrepreneurship at Office of Technology
Transfer, National Institutes of Health
BREAK
Chesapeake, White Oak
37
TUESDAY SCHEDULE CONTINUED
10:45 - 11:45 AM
Biomedical Policy: Disruptive Innovation to Accelerate Discovery
Main Atrium
Moderator:
Richard A. Williams, PhD Vice President, Policy Research, Mercatus Center
at George Mason University
38
TUESDAY SCHEDULE CONTINUED
2:20 - 3:20 PM
Idea Challenge: An Exercise in Innovation (Case Competition)
Main Atrium
3:20 - 4:00 PM
The Next 50: The Future of the Biotech Enterprise
Main Atrium
Panelists:
Gene G. Olinger, Jr., PhD, MBA MRI Global Contractor, National Institute of Allergy
and Infectious Diseases (NIAID), National Institutes of Health
Moderators:
Marina Carla Cabrera, PhD President, Leaders of Tomorrow Summit
Justin Hanes, PhD Lewis J. Ort Endowed Professor of Ophthalmology; Director of the
Center for Nanomedicine, Johns Hopkins University School of Medicine;
Founder, Graybug, Kala
Panelists:
Harriet Fear Chief Operating Officer, One Nucleus UK
Kirill Gorshkov Vice President, Leaders of Tomorrow Summit
Drew Pardoll, MD, PhD Professor of Oncology, Medicine, Pathology, Molecular Biology,
and Genetics; Director, Cancer Immunology Program, Johns Hopkins University;
Founder, Amplimmune
Andreas Seiter, MD Senior Health Specialist – Pharmaceuticals, The World Bank Group
John Finkbohner, PhD, RAC Senior Regional Policy Director, AstraZeneca
Ronald Bailey Science Correspondent, Reason Magazine
Steven Ferguson, MS, MBA, CLP Deputy Director, Licensing and Entrepreneurship,
Office of Technology Transfer, National Institutes of Health
Robert Graboyes, PhD Senior Research Fellow, Mercatus Center at George Mason
University
11:45 - 12:45 PM
12:45 - 1:00 PM
LUNCH
Cafe Atrium
LUNCH KEYNOTE ADDRESS
Main Atrium
Pascal Soriot, Executive Director and Chief Executive Officer, AstraZeneca
1:00 - 1:20 PM
KEYNOTE: Tissue Phenomics - A Novel Big Data Approach in Medicine
Main Atrium
Gerd Binnig, PhD Nobel Laureate, Founder and Chief Technology Officer of Definiens
1:20 - 2:20 PM
Discovery Today, Innovation Tomorrow
Main Atrium
Moderator:
Thomas P. Caruso, PhD, MBA, PMP Health Informatics Liaison,
University of North Carolina at Chapel Hill
Panelists:
Ivor Royston, MD Founding Managing Partner, Forward Ventures
Michael Weingarten, MA Director, Small Business Innovation Research (SBIR)
and Small Business Technology Transfer (STTR) Programs, National Cancer Institute
Christian Plaza, JD Partner, Cooley LLP
Sara Nayeem, MD, MBA Principal, New Enterprise Associates
Kevin Owen, PhD Chief Operating Officer, Rivanna Medical
4:00 - 5:00 PM
WRAP-UP PLENARY
Main Auditorium
Jarrod Borkat, Head, External Collaborations and Biotech Hubs,
Senior Director, MedImmune
Reginald Seeto, MD, Vice President, Head of Partnering and Strategy, MedImmune
OUR PARTNERS AND
SPONSORS
LEADERS OF
TOMORROW SUMMIT 2015
ABBREVIATED AGENDA
39
TIME
SESSION
LOCATION
07:30 – 08:00 am
Registration and Breakfast
Main Atrium
08:15 – 08:30 am
Summit Opening Introduction
Main Atrium
08:30 – 09:30 am
Culturing Next-Gen Leaders for
Tomorrow’s Bioeconomy
Main Atrium
09:40 – 10:00 am
PLENARY: The Importance of the MD/DC/VA
Main Auditorium
Region to Growing Companies: An AZ Perspective
Pascal Soriot, Executive Director and Chief
Executive Officer, AstraZeneca
10:00 – 10:30 am
KEYNOTE: Academic-Industry
Perspective Plenary
Marc Tessier-Lavigne, PhD, President,
Rockefeller University
Main Auditorium
10:30 – 10:45 am
Break
Chesapeake & White Oak
10:45 – 11:45 am
Biomedical Policy: Disruptive Innovation to
Accelerate Discovery
Main Atrium
11:45 – 12:45 pm
Lunch
Café Atrium
12:45 – 01:00 pm
Lunch Keynote Address
Pascal Soriot, Executive Director and Chief
Executive Officer, AstraZeneca
Main Atrium
01:00 – 01:20 pm
KEYNOTE: Tissue Phenomics - A Novel Big Data
Approach in Medicine
Gerd Binnig, PhD, Nobel Laureate, Founder and
Main Atrium
01:20 – 02:20 pm
Discovery Today, Innovation Tomorrow
Main Atrium
02:20 – 03:20 pm
Idea Challenge: An Exercise in Innovation
(Case Competition)
Main Atrium
03:20 – 04:00 pm
The Next 50: The Future of the
Biotech Enterprise
Main Atrium
04:00 – 05:00 pm
Wrap-Up Plenary
Main Auditorium
40
Inaugural
GapSummit
USA coming in
2016
DOWNLOAD THIS PROGRAM @ FUTURELEADERS2015.COM